Monoamine Oxidases in Smoking Pregnant Women and Newborns

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

59 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-03-31

Study Completion Date

2007-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Smoking substantially inhibits the activities of both monamine oxidase (MAO) A and B enzymes.

Aims of this study: to compare MAO activities and nicotine and cotinine in peripheral blood of smoking and nonsmoking pregnant women, in their placenta and in cord blood and relate them with the behavior of their newborns being observed during 48 hours after birth.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Maternal Smoking Exposure and Newborn Outcomes: Study Using Urinary Cotinine

NCT07201181

Tobacco Smoke Pollution Maternal Exposure During Pregnancy Infant, Newborn +1 more

NOT_YET_RECRUITING

Pregnant Women's Knowledge of the Active and Passive Smoking Effects on Pregnancy and the Fetus

NCT06117943

Pregnant Women's Tabacco Exposure

UNKNOWN

Obstetric Complications in Women Who Smoke During Pregnancy

NCT01758276

Smoking

UNKNOWN

Maternal Smoking During Pregnancy and Female Fetal Testosterone Levels

NCT02610751

Smoking

COMPLETED

Impact of Expired Carbon Monoxide Measurement on Smoking Cessation of Pregnant Women

NCT03842449

Smoking Cessation

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

40 pregnant smoking and 40 pregnant nonsmoking women will be included at the end of the 2nd trimester.

Assessments: smoking characteristics, plasma cotinine, DHPG, DOPAC, 5HIAA concentrations reflecting MAOA activity and platelet MAOB activity will be measured just after inclusion (end of 2nd trimester), just before delivery in venous maternal blood and just after delivery in cord blood.

The newborns' behavior (wellbeing) will be assessed every 8 hour after birth for 2 days.

Comparisons will be made between smoking and nonsmoking women and their newborns.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Pregnancy Newborn

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

pregnant smokers

No interventions assigned to this group

pregnant non smokers

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pregnancy of 5 or 6 months
* nonsmokers: lifetime smoking of less than 100 cigarettes; smokers: unable to stop smoking during the first 3 months of pregnancy; smoking at least 10 cigarettes/day.

Exclusion Criteria

* pathological pregnancies
* opioid dependence; alcoholism.
* chronic psychiatric, hematological, neurological disorders
* eclampsia
* chronic antidepressant or neuroleptic treatment
* current nicotine replacement therapies

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No